Estimated read time: 3-4 minutes
This archived news story is available only for your personal, non-commercial use. Information in the story may be outdated or superseded by additional information. Reading or replaying the story in its archived form does not constitute a republication of the story.
[STK]
[IN] HEA MTC MEQ
[SU] LIC PDT
TO BUSINESS, AND MEDICAL EDITORS:
Intronix Technologies Announces New Canadian Distributor for
MyoguideT, the Latest Guided Injection System Innovation
TORONTO, March 5, 2014 /PRNewswire/ -- Leading medical equipment
designer Intronix Technologies (http://www.intronixtech.com) is
pleased to introduce NeuroSource Medical as their new Canadian
distributor for the MyoguideT Needle EMG Guided Injection System.
NeuroSource Medical (http://www.Neuro-Source.com) is a team comprised
of Canadian professionals with over 30 years combined experience. They
not only supply customers with EMG, NCV, IONM, EEG and Sleep
accessories, but also pledge a support system with unparalleled
service, expertise and professionalism. As the new Canadian
distributor for MyoguideT, NeuroSource provides yet another invaluable
service for its customers.
Intronix's breakthrough MyoguideT injection system promises safer,
more effective medication delivery for the treatment of myofascial
pain, spasticity and fibromyalgia. Although MyoguideT is most commonly
utilized with Botox@ and similar drugs, the potential applications for
the system are numerous.
Team Myoguide Canada has also partnered with Ambu
(http://www.ambuusa.com) to provide Ambu's high-quality electrode
sample packs, complimentary with every Myoguide unit purchased from
NeuroSource.
This new partnership presents a unique opportunity of which Canadian
clients will be able to take full advantage. Dr. Evan Friedman,
president of Intronix Technologies, announces, "With Ambu on our
support team, Intronix can now provide our Canadian clinician
customers with samples of Ambu's Neuroline hypodermic needle
electrodes and surface electrode product lines."
The Ambu Inoject Needle administers high-caliber performance at the
top of its class for EMG guided injectable needles. Inoject needles
complement Myoguide injection guidance technology to afford
exceptional results for patients. Ambu's needles secure Botox@ with a
Lure-Lock hub and are compatible with any syringe from 1cc and up. The
Ambu Inoject Needle also delivers complete patient comfort, from the
superior sharpness for skin penetration, to the extreme smoothness for
easy gliding through muscle.
About NeuroSource Medical
With its headquarters located in London Ontario, NeuroSource Medical
is Canada's leading accessory provider of all neurology
EMG/EEG/EP/IONM and Sleep diagnostic testing and monitoring. More than
just a simple distributor, NeuroSource Medical (www.Neuro-Source.com)
has actively participated in the development of most of the products
it sells. Its wealth of neurophysiology expertise provides its
customers with a product backed by experience. This combination of
knowledge and experience has elevated NeuroSource Medical above a
simple distribution model and has served to further strengthen our
relationships with the Canadian Medical Community. For more
information please contact Dr. Brad Watsonbwatson@neuro-source.com, or
visit our website at www.Neuro-Source.com.
About Ambu
Ambu (AMBU-B Copenhagen A/S) develops, produces and markets diagnostic
and life-supporting devices for hospitals and rescue services. Its
most notable products include artificial-respiration ventilation
solutions and single-use electrodes for ECG tests and
neurophysiological mappings. With corporate headquarters in Ballerup,
Denmark and the United States headquarters in Glen Burnie, Md., Ambu
employs approximately 1,700 people worldwide. For more information,
visit www.ambuusa.com or contact Dan Toomey: dct@ambu.com.
About Intronix Technologies Corporation
Located just outside Toronto, Ontario, Intronix Technologies
Corporation designs and produces progressive electromyographic (EMG)
systems for applications in the diagnosis and management of myofascial
pain, spasticity, and fibromyalgia. Its innovations in injection
guidance provide technology that drives clinical solutions to deliver
confidence, improve workflow efficiency, and provide a better patient
experience. Intronix Technologies is known for its exceptional
equipment, plus its comprehensive customer-support programs that are
developed to maximize the lifecycle value of equipment through
responsive service maintenance and significant software support. Learn
more at http://www.intronixtech.com.
Contact:
Dr. Evan Friedman President, Intronix Technologies Corporation
800-819-9996 Email
Read more news from Intronix Technologies Corporation.
SOURCE Intronix Technologies Corporation
-0- 03/05/2014
/Web Site: http://www.intronixtech.com
CO: Intronix Technologies Corporation; NeuroSource Medical; Ambu
ST: Ontario Canada
IN: HEA MTC MEQ
SU: LIC PDT
PRN
-- PH76632 --
0000 03/05/2014 13:30:00 EDT http://www.prnewswire.com
Copyright © The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
